FDA panel backs much-debated ALS drug in rare, 2nd review

The Food and Drug Administration advisers voted 7-2 that data from Amylyx Pharma warranted approval, despite ongoing concerns about the strength and reliability of the company’s study. The vote is not binding a

Related Keywords

China ,Cambridge ,Cambridgeshire ,United Kingdom ,Washington ,United States ,Massachusetts ,Chinese ,Matthew Perrone ,Tristan Massie ,Billy Dunn ,Justin Klee ,Lou Gehrig ,Tina Locurto ,Amylyx Pharma ,Michael Casey ,Caleb Alexander ,Johns Hopkins University ,Indiana University School Of Medicine ,National Institutes Of Health ,Facebook ,Drug Administration ,Associated Press ,Wellspan York ,York Hospital ,York County ,Liana Apostolova ,Indiana University ,Dean Follmann ,National Institutes ,Greg Canter ,